Expert consensus (2024 PMC review)
GLP-1 medications can be powerful tools for appetite control and weight loss but without the right nutrition strategy, you risk muscle loss, fatigue, nutrient deficiencies, and stalled progress
A protocol focused narrowly on energy metabolism might use NAD+ (and 5-Amino-1MQ) alone
The fibrinogen level decrease observed in the Cohort 2 LCLT group reflects previous reporting of decreased plasma fibrinogen levels in hemodialysis patients who received LC supplementation (21)
conversely, normal SQOR activity eliminated excess sulfide and preserved CoQ 10 H 2 s antioxidant function, thereby mitigating cisplatin-induced oxidative damage and protecting the kidney (Cai et al., 2024)
Incidence rates for the 4 outcomes were elevated among GLP-1 agonists compared with bupropion-naltrexone users (Table 1)